See analyst estimates and all valuation multiples for Pharma Diagnostics & Analytics
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $10.6B | 8.7x | 24.7x | |
| $7.1B | 24.0x | 565.7x | |
| $2.4B | 9.0x | -1159.9x | |
| $1.5B | 5.1x | -12.2x | |
| $1.1B | 20.0x | n/a | |
| $369M | 168.3x | -11.4x | |
| $315M | n/a | n/a | |
| $194M | 60.3x | -9.5x | |
| $181M | 3.3x | 18.4x | |
| $153M | n/a | -2.4x | |
| $117M | 6.7x | 8.8x | |
| $101M | 11.7x | -5.0x | |
| $66.9M | n/a | n/a | |
| $55.5M | 3.0x | 16.4x | |
| $43.8M | 16.3x | -8.6x | |
| $26.4M | 28.3x | -11.3x | |
| $2.0M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharma Diagnostics & Analytics